Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
Feb. 28, 2021
Aug. 31, 2020
Current Assets    
Cash and cash equivalents $ 10,706,431 $ 2,142,072
Marketable securities 512,030 0
Prepaid expenses other current assets 186,735 195,127
Total Current Assets 11,405,196 2,337,199
Equipment, net of accumulated depreciation of $1,502 and $1,363, respectively 124 246
Intangible asset 2,039,417 2,039,417
TOTAL ASSETS 13,444,737 4,376,862
Current Liabilities    
Accounts payable and accrued liabilities 583,966 490,218
Due to related party 5,000 11,959
Total Current Liabilities 588,966 502,177
STOCKHOLDERS' EQUITY    
Preferred Stock, par value $0.001, 6,250,000 shares authorized, 0 shares issued and outstanding 0 0
Common Stock, par value $0.001, 750,000,000 shares authorized, 22,213,112 and 4,991,587 shares issued and outstanding, respectively 22,213 4,992
Additional paid-in capital 25,551,842 13,271,549
Accumulated deficit (12,766,184) (9,465,618)
Accumulated other comprehensive income 47,900 63,762
Total Stockholders' Equity 12,855,771 3,874,685
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 13,444,737 $ 4,376,862